Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Sexually Transmitted Diseases

Free Subscription Articles published in J Infect Dis Retrieve available abstracts of 93 articles: HTML format Text format

Single Articles

May 2018
1. PAMNANI SJ, Sudenga SL, Rollison DE, Ingles DJ, et al
   Recurrence of Genital Infections with Nine HPV Vaccine Types (6, 11, 16, 18, 31, 33, 45, 52, and 58) among Men in the HPV Infection in Men (HIM) Study.
   J Infect Dis. 2018 May 24. pii: 5002064. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
2. MARIAGGI AA, Pere H, Perrier M, Visseaux B, et al
   Presence of HPV APOBEC-related Minority Variants in HPV16 Genomes from Anal and Cervical Samples but not in HPV52 and HPV58.
   J Infect Dis. 2018 May 17. pii: 4997032. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
3. TWISK DE, van der Sande MAB, van Eeden A, Heideman DAM, et al
   Detection of Incident Anal High-Risk Hpv-Dna in Msm: Incidence or Reactivation?
   J Infect Dis. 2018 May 16. pii: 4996623. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   April 2018
4. SAFAEIAN M, Castellsague X, Hildesheim A, Wacholder S, et al
   Risk of HPV-16/18 Infections and Associated Cervical Abnormalities in Women Seropositive for Naturally Acquired Antibodies: Pooled Analysis Based on Control Arms of Two Large Clinical Trials.
   J Infect Dis. 2018 Apr 30. pii: 4990620. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
5. GAO K, Shen X, Lin Y, Zhu XZ, et al
   Origin of Nontreponemal Antibodies During Treponema pallidum Infection: Evidence From a Rabbit Model.
   J Infect Dis. 2018 Apr 25. pii: 4985700. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   February 2018
6. ARTEMCHUK H, Triglav T, Ostrbenk A, Poljak M, et al
   Seroprevalences for 11 Human Papillomavirus (HPV) Types Mark Cumulative HPV Exposure.
   J Infect Dis. 2018 Feb 26. pii: 4909742. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
7. KOJIC EM, Conley L, Bush T, Cu-Uvin S, et al
   Prevalence and Incidence of Anal and Cervical High-Risk Human Papillomavirus (HPV) Types covered by Current HPV Vaccines among HIV-Infected Women in the Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (The SUN Study
   J Infect Dis. 2018 Feb 14. pii: 4857222. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
8. MACHALEK DA, Garland SM, Brotherton JML, Bateson D, et al
   Very low prevalence of vaccine human papillomavirus (HPV) types among 18 to 35 year old Australian women, nine years following implementation of vaccination.
   J Infect Dis. 2018 Feb 7. pii: 4841780. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
9. DONKEN R, King AJ, Bogaards JA, Woestenberg PJ, et al
   High effectiveness of the bivalent HPV vaccine up to six years post-vaccination against incident and persistent HPV infections in young Dutch females.
   J Infect Dis. 2018 Feb 2. pii: 4835373. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
10. POLLOCK KGJ
    Sustained cross-protection of the bivalent HPV vaccine.
    J Infect Dis. 2018 Feb 2. pii: 4835375. doi: 10.1093.
    PubMed     Text format    
    
    
    December 2017
11. TANSEY C, Zhao C, Hopkins A, Ritter JM, et al
    A Non-human Primate Model for Rectally Transmitted Syphilis.
    J Infect Dis. 2017 Dec 22. pii: 4772175. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
12. EASTMAN AJ, Bergin IL, Chai D, Bassis CM, et al
    Impact of the Levonorgestrel-Releasing Intrauterine System on the Progression of Chlamydia trachomatis Infection to Pelvic Inflammatory Disease in a Baboon Model.
    J Infect Dis. 2017 Dec 15. pii: 4743781. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
13. NYITRAY AG, Fujimoto K, Zhao J, Giuliano AR, et al
    Prevalence of and risk factors for anal HPV among a sample of predominantly black men who have sex with men in Houston, Texas.
    J Infect Dis. 2017 Dec 5. pii: 4690591. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
14. PATEL P, Bush T, Kojic EM, Conley L, et al
    Prevalence, incidence, and clearance of anal high-risk human papillomavirus (HPV) infection among HIV-infected men in the SUN Study.
    J Infect Dis. 2017 Dec 4. pii: 4689803. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    November 2017
15. BAVOIL PM, Marques PX, Brotman R, Ravel J, et al
    Does Active Oral Sex Contribute to Female Infertility?
    J Infect Dis. 2017;216:932-935.
    PubMed     Text format     Abstract available
    
    
    
16. WOESTENBERG PJ, King AJ, van Benthem BHB, Donken R, et al
    Bivalent vaccine effectiveness against type-specific HPV positivity: evidence for cross-protection against oncogenic types among Dutch STI clinic visitors.
    J Infect Dis. 2017 Nov 11. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
17. NOVAKOVIC D, Cheng ATL, Zurynski Y, Booy R, et al
    A Prospective Study of the Incidence of Juvenile-Onset Recurrent Respiratory Papillomatosis After Implementation of a National HPV Vaccination Program.
    J Infect Dis. 2017 Nov 9. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    September 2017
18. DROLET M, Laprise JF, Brotherton JML, Donovan B, et al
    The impact of human papillomavirus catch-up vaccination in Australia: Implications for introduction of multiple age cohort vaccination and post-vaccination data interpretation.
    J Infect Dis. 2017 Sep 12. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
19. MALAGON T, Burchell AN, El-Zein M, Guenoun J, et al
    Estimating HPV DNA deposition between sexual partners using HPV concordance, Y chromosome DNA detection, and self-reported sexual behaviours.
    J Infect Dis. 2017 Sep 9. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
20. RYSER MD, Rositch A, Gravitt PE
    Modeling of US Human Papillomavirus (HPV) Seroprevalence by Age and Sexual Behavior Indicates an Increasing Trend of HPV Infection Following the Sexual Revolution.
    J Infect Dis. 2017;216:604-611.
    PubMed     Text format     Abstract available
    
    
    
21. OLIVER SE, Unger ER, Lewis R, McDaniel D, et al
    Prevalence of Human Papillomavirus Among Females After Vaccine Introduction-National Health and Nutrition Examination Survey, United States, 2003-2014.
    J Infect Dis. 2017;216:594-603.
    PubMed     Text format     Abstract available
    
    
    August 2017
22. TUITE AR, Gift TL, Chesson HW, Hsu K, et al
    Impact of rapid susceptibility testing and antibiotic selection strategy on the emergence and spread of antibiotic resistance in gonorrhea.
    J Infect Dis. 2017 Aug 31. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
23. LEHTINEN T, Soderlund-Strand A, Petaja T, Eriksson T, et al
    Human papillomavirus (HPV) prevalence in adolescent males four years post HPV16/18 vaccination.
    J Infect Dis. 2017 Aug 24. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
24. DE POKOMANDY A, Kaufman E, de Castro C, Mayrand MH, et al
    The EVVA Cohort Study: Anal and Cervical Type-Specific Human Papillomavirus Prevalence, Persistence, and Cytologic Findings in Women Living With HIV.
    J Infect Dis. 2017;216:447-456.
    PubMed     Text format     Abstract available
    
    
    
25. BAUSSANO I, Lazzarato F, Ronco G, Lehtinen M, et al
    Different Challenges in Eliminating HPV16 Compared to Other Types: A Modeling Study.
    J Infect Dis. 2017;216:336-344.
    PubMed     Text format     Abstract available
    
    
    July 2017
26. LEWIS J, Price MJ, Horner PJ, White PJ, et al
    Genital Chlamydia trachomatis Infections Clear More Slowly in Men Than Women, but Are Less Likely to Become Established.
    J Infect Dis. 2017;216:237-244.
    PubMed     Text format     Abstract available
    
    
    
27. GOLDEN MR, Workowski KA, Bolan G
    Developing a Public Health Response to Mycoplasma genitalium.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
    
28. MCGOWIN CL, Totten PA
    The Unique Microbiology and Molecular Pathogenesis of Mycoplasma genitalium.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
    
29. HAMPRAS SS, Rollison DE, Giuliano AR, McKay-Chopin S, et al
    Prevalence and Concordance of Cutaneous Beta Human Papillomavirus Infection at Mucosal and Cutaneous Sites.
    J Infect Dis. 2017;216:92-96.
    PubMed     Text format     Abstract available
    
    
    June 2017
30. HUANG LM, Puthanakit T, Cheng-Hsun C, Ren-Bin T, et al
    Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9-14 Years: A Randomized Trial.
    J Infect Dis. 2017 Jun 7. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
31. QENDRI V, Bogaards JA, Berkhof J
    Health and economic impact of a tender-based gender-neutral HPV16/18 vaccination program in the Netherlands.
    J Infect Dis. 2017 Jun 6. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    May 2017
32. JORDAN SJ, Olson KM, Barnes S, Wilson LS, et al
    Lower Levels of Cervicovaginal Tryptophan are Associated with Natural Clearance of Chlamydia in Women.
    J Infect Dis. 2017 May 17. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
33. STEINAU M, Gorbach P, Gratzer B, Braxton J, et al
    Concordance between Anal and Oral Human Papillomavirus (HPV) Infections Among Young Men Who Have Sex with Men.
    J Infect Dis. 2017 May 15. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    April 2017
34. BAKSHI R, Gupta K, Jordan SJ, Brown LT, et al
    Immunoglobulin-Based Investigation of Spontaneous Resolution of Chlamydia trachomatis Infection.
    J Infect Dis. 2017 Apr 21. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
35. PATEL EU, Rositch AF, Gravitt PE, Tobian AAR, et al
    Concordance of Penile and Oral Human Papillomavirus Infections Among Men in the United States.
    J Infect Dis. 2017;215:1207-1211.
    PubMed     Text format     Abstract available
    
    
    March 2017
36. SUCHLAND RJ, Dimond ZE, Putman TE, Rockey DD, et al
    Whole-genome sequencing of repeat-positive, same-serovar Chlamydia trachomatis collected from the female genital tract demonstrate persistent infections and genome stability.
    J Infect Dis. 2017 Mar 23. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
37. KOTTARIDI C, Kyrgiou M, Pouliakis A, Magkana M, et al
    Quantitative Measurement of L1 Human Papillomavirus Type 16 Methylation for the Prediction of Preinvasive and Invasive Cervical Disease.
    J Infect Dis. 2017;215:764-771.
    PubMed     Text format     Abstract available
    
    
    February 2017
38. SHANNON B, Gajer P, Yi TJ, Ma B, et al
    Distinct effects of the cervico-vaginal microbiota and herpes simplex type 2 infection on female genital tract immunology.
    J Infect Dis. 2017 Feb 13. doi: 10.1093.
    PubMed     Text format    
    
    
    
39. RODAS PI, Perez D, Jauffret C, Gonzalez Y, et al
    Modified Profile of Matrix Metalloproteinase 2 and 9 Production by Human Fallopian Tube Epithelial Cells After Infection In Vitro With Neisseria gonorrhoeae.
    J Infect Dis. 2017;215:452-455.
    PubMed     Text format     Abstract available
    
    
    January 2017
40. BERNSTEIN DI, Wald A, Warren T, Fife K, et al
    Therapeutic Vaccine for Genital Herpes Simplex Virus-2 Infection: Findings from a Randomized Trial.
    J Infect Dis. 2017 Jan 30. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    December 2016
41. FLORES-DIAZ E, Sereday KA, Ferreira S, Sirak B, et al
    HPV-6 molecular variants association with the development of genital warts in men: The HIM Study.
    J Infect Dis. 2016 Dec 23. pii: jiw600. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
42. DONKEN R, Schurink-van 't Klooster TM, Schepp RM, van der Klis FR, et al
    Immune responses after two- versus three-doses of HPV vaccination up to 4(1/2) years post vaccination: an observational study among Dutch routinely vaccinated girls (HPV2D).
    J Infect Dis. 2016 Dec 23. pii: jiw588. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
43. HEARD I, Tondeur L, Arowas L, Demazoin M, et al
    Effectiveness of HPV vaccination on prevalence of vaccine genotypes in young sexually active women in France.
    J Infect Dis. 2016 Dec 23. pii: jiw639. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
44. GRABOWSKI MK, Gravitt PE, Gray RH, Serwadda D, et al
    Trends and determinants of human papillomavirus concordance among HIV-positive and HIV-negative heterosexual couples in Rakai, Uganda.
    J Infect Dis. 2016 Dec 23. pii: jiw631. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
45. MESQUITA PM, Preston-Hurlburt P, Keller MJ, Vudattu N, et al
    Role of IL-32 in HIV Reactivation and its Link to HIV-HSV Coinfection.
    J Infect Dis. 2016 Dec 22. pii: jiw612. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
46. GEORGE Z, Omosun Y, Azenabor AA, Partin J, et al
    The roles of unfolded protein response pathways in Chlamydia pathogenesis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    November 2016
47. BERENSON AB, Laz TH, Rahman M
    Reduction in vaccine-type human papillomavirus prevalence among adult females in the United States, 2009-2012.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    
48. MACHALEK DA, Chow EP, Garland SM, Wigan R, et al
    Human papillomavirus prevalence in unvaccinated heterosexual males following a national female vaccination program.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    October 2016
49. SCHLECHT NF, Diaz A, Shankar V, Szporn AH, et al
    RISK OF DELAYED HPV VACCINATION IN INNER-CITY ADOLESCENT WOMEN.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    
50. RUSSELL AN, Zheng X, O'Connell CM, Wiesenfeld HC, et al
    Identification of Chlamydia trachomatis antigens recognized by T cells from highly exposed women who limit or resist genital tract infection.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    September 2016
51. GRAD YH, Harris SR, Kirkcaldy RD, Green AG, et al
    Genomic epidemiology of gonococcal resistance to extended spectrum cephalosporins, macrolides, and fluoroquinolones in the US, 2000-2013.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    August 2016
52. REIMERS LL, Mehta SD, Massad LS, Burk RD, et al
    The Cervicovaginal Microbiota and Its Associations with Human Papillomavirus (HPV) Detection in HIV-Infected and HIV-Uninfected Women.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    
53. PINTO LA, Kemp TJ, Torres BN, Isaacs K, et al
    THE QUADRIVALENT HPV VACCINE INDUCES HPV-SPECIFIC ANTIBODIES AT THE ORAL CAVITY: RESULTS FROM THE MID-ADULT MALE VACCINE TRIAL-THE MAM TRIAL.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    
54. PAMNANI SJ, Nyitray AG, Abrahamsen M, Rollison DE, et al
    Sequential acquisition of anal HPV infection following genital infection among men who have sex with women: the HPV Infection in Men (HIM) Study.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    June 2016
55. MATTHIJSSE SM, Hontelez JA, Naber SK, Rozemeijer K, et al
    Public health benefits of routine human papillomavirus vaccination for adults in the Netherlands: a mathematical modeling study.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    
56. MEITES E, Gorbach PM, Gratzer B, Panicker G, et al
    Monitoring for HPV Vaccine Impact among Gay, Bisexual and other Men who have Sex with Men - United States, 2012-2014.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    
57. PRICE MJ, Ades AE, Welton NJ, Simms I, et al
    Proportion of Pelvic Inflammatory Disease Cases Caused by Chlamydia trachomatis: Consistent Picture From Different Methods.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    
58. TOTA JE, Ramanakumar AV, Villa LL, Richardson H, et al
    Cervical Infection with Vaccine Human Papillomavirus (HPV) Genotypes as a Predictor of Acquisition and Clearance of Other HPV Infections.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    May 2016
59. LAPRISE JF, Markowitz LE, Chesson HW, Drolet M, et al
    COMPARING 2- AND 3-DOSE 9-VALENT HPV VACCINE SCHEDULES IN THE U.S.: A COST-EFFECTIVENESS ANALYSIS.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    April 2016
60. MILMAN N, Zhu J, Johnston C, Cheng A, et al
    In Situ Detection of Regulatory T Cells in Human Genital Herpes Simplex Virus Type 2 (HSV-2) Reactivation and Their Influence on Spontaneous HSV-2 Reactivation.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    March 2016
61. GRAVITT PE, Marks M, Kosek M, Huang C, et al
    Soil-Transmitted Helminth Infections Are Associated With an Increase in Human Papillomavirus Prevalence and a T-Helper Type 2 Cytokine Signature in Cervical Fluids.
    J Infect Dis. 2016;213:723-30.
    PubMed     Text format     Abstract available
    
    
    February 2016
62. PIERCE CAMPBELL CM, Viscidi RP, Torres BN, Lin HY, et al
    Human papillomavirus (HPV) L1 serum antibodies and risk of subsequent oral HPV acquisition in men: The HIM Study.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    
63. D'SOUZA G, Wentz A, Kluz N, Zhang Y, et al
    Gender differences in risk factors and natural history of oral human papillomavirus (HPV) infection.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    
64. CHESSON HW, Laprise JF, Brisson M, Markowitz LE, et al
    The Impact and Cost-Effectiveness of 3 doses of 9-Valent Human Papillomavirus (HPV) Vaccine among US Females Previously Vaccinated with 4-Valent HPV Vaccine.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    
65. MEYS R, Purdie KJ, de Koning MN, Quint KD, et al
    HLA immunogenotype determines persistent HPV infection in anti-retroviral treated HIV.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    
66. PUTHANAKIT T, Huang LM, Chiu CH, Tang RB, et al
    A randomised open trial comparing 2-dose regimens of the HPV-16/18 AS04-adjuvanted vaccine in girls aged 9-14 years versus 3 doses in women aged 15-25 years.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    January 2016
67. RADZIO J, Henning T, Jenkins L, Ellis S, et al
    Combination emtricitabine and tenofovir disoproxil fumarate prevents vaginal SHIV infection in macaques harboring C. trachomatis and T. vaginalis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    December 2015
68. FIFE KH, Mugwanya K, Thomas KK, Baeten JM, et al
    Transient Increase in HSV-2-Associated Genital Ulcers Following Initiation of Antiretroviral Therapy in HIV-1/HSV-2 Co-Infected Individuals.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available
    
    
    
69. BEACHLER DC, Jenkins G, Safaeian M, Kreimer AR, et al
    Natural acquired immunity against subsequent genital HPV infection: a systematic review and meta-analysis.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available
    
    
    
70. HEARD I, Poizot-Martin I, Potard V, Etienney I, et al
    Prevalence of and risk factors for Anal Oncogenic human papillomavirus infection among HIV-Infected Women in France in the cART era.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available
    
    
    
71. SCHILLER JT, Lowy DR
    Reply to Nalin.
    J Infect Dis. 2015;212:2021-2.
    PubMed     Text format    
    
    
    
72. MARRA CM, Tantalo LC, Sahi SK, Dunaway SB, et al
    Treponema pallidum-specific Opsonic Antibody Activity is Reduced in HIV-Infected Patients with Syphilis.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available
    
    
    November 2015
73. GRABOWSKI MK, Kong X, Gray RH, Serwadda D, et al
    Partner human papillomavirus viral load and incident human papillomavirus detection in heterosexual couples.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available
    
    
    October 2015
74. HARARI A, Chen Z, Rodriguez AC, Hildesheim A, et al
    Cross-protection of the bivalent human papillomavirus (HPV) vaccine against variants of genetically related high-risk HPV infections.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available
    
    
    
75. GRAD YH, Goldstein E, Lipsitch M, White PJ, et al
    Improving control of antibiotic resistant gonorrhea by integrating research agendas across disciplines: key questions arising from mathematical modeling.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available
    
    
    
76. PHIPPS W, Nakku-Joloba E, Krantz EM, Selke S, et al
    Genital Herpes Simplex Virus Type 2 Shedding Among Adults With and Without HIV Infection in Uganda.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available
    
    
    
77. LOW AJ, Nagot N, Weiss HA, Konate I, et al
    Herpes simplex virus type-2 (HSV-2) cervico-vaginal shedding among women living with HIV-1 on antiretroviral therapy in Burkina Faso: an 8-year longitudinal study.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available
    
    
    September 2015
78. RUSSELL AN, Zheng X, O'Connell CM, Taylor BD, et al
    Analysis of factors driving incident and ascending infection and the role of serum antibody in Chlamydia trachomatis genital tract infection.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available
    
    
    August 2015
79. GRAVITT PE
    HPV Seroprevalence in the United States: Behavior, Biology, and Prevention.
    J Infect Dis. 2015.
    PubMed     Text format    
    
    
    
80. LIU G, Markowitz LE, Hariri S, Panicker G, et al
    Seroprevalence of 9 Human Papillomavirus Types in the United States, 2005-2006.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available
    
    
    
81. NALIN DR
    Single-Dose Vaccines.
    J Infect Dis. 2015.
    PubMed     Text format    
    
    
    
82. CONLEY LJ, Bush TJ, Darragh TM, Palefsky JM, et al
    Incidence and Predictors For Development of Abnormal Anal Cytology Among HIV-infected Adults Receiving Contemporary Antiretroviral Therapy.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available
    
    
    July 2015
83. ELFSTROM KM, Lazzarato F, Franceschi S, Dillner J, et al
    Human papillomavirus vaccination of boys and extended catch-up vaccination: Effects on the resilience of programs.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available
    
    
    June 2015
84. DUNNE EF, Naleway A, Smith N, Crane B, et al
    Reduction in HPV vaccine type prevalence among young women screened for cervical cancer in an integrated health care delivery system, United States 2007, 2012-2013.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available
    
    
    
85. MANAM S, Thomas JD, Li W, Maladore A, et al
    Tumor Necrosis Factor (TNF) Receptor Superfamily Member 1b on CD8+ T Cells and TNF Receptor Superfamily Member 1a on Non-CD8+ T Cells Contribute Significantly to Upper Genital Tract Pathology Following Chlamydial Infection.
    J Infect Dis. 2015;211:2014-22.
    PubMed     Text format     Abstract available
    
    
    
86. BENDER IGNACIO RA, Perti T, Magaret AS, Rajagopal S, et al
    Oral and gel tenofovir for genital HSV-2 shedding in immunocompetent women: a double-blind randomized cross-over trial (128/160 chars&spaces).
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available
    
    
    May 2015
87. BEACHLER DC, Guo Y, Xiao W, Burk RD, et al
    High oral HPV16 viral load predicts long-term persistence in HIV-infected and at risk HIV-uninfected individuals.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available
    
    
    
88. GRABOWSKI MK, Kigozi G, Gray RH, Armour B, et al
    HSV-2 shedding from male circumcision wounds in Rakai, Uganda.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available
    
    
    
89. HAMPRAS SS, Giuliano AR, Lin HY, Fisher KJ, et al
    Natural history of polyomaviruses in men: the HPV infection in men (HIM) study.
    J Infect Dis. 2015;211:1437-46.
    PubMed     Text format     Abstract available
    
    
    March 2015
90. GIANELLA S, Redd AD, Grabowski MK, Tobian AA, et al
    Vaginal Cytomegalovirus Shedding before and after Initiation of Antiretroviral Therapy in Rakai, Uganda.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available
    
    
    February 2015
91. MULLER K, Kazimiroff J, Fatahzadeh M, Smith RV, et al
    Oral Human Papillomavirus and Oral Lesions In HIV-positive and HIV-negative Dental Patients.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available
    
    
    
92. NYITRAY AG, Chang M, Villa LL, Carvalho da Silva RJ, et al
    The natural history of genital human papillomavirus among HIV-negative men having sex with men and men having sex with women.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available
    
    
    January 2015
93. ESBER A, Vicetti Miguel RD, Cherpes TL, Klebanoff M, et al
    Risk of bacterial vaginosis among women with herpes simplex virus type 2 infection: a systematic review and meta-analysis.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Sexually Transmitted Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: